Ascertain Named to the 2026 New York Digital Health 100

New York, NY (February 3, 2026)

Ascertain announced today that it has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in conjunction with the 2026 New York Healthcare Innovation Report, which analyzes key investment trends, market dynamics, and opportunities shaping the digital health ecosystem.

Now in its seventh year, the DH100 spotlights the companies driving healthcare forward through bold ideas and scalable solutions. The 2026 list includes 48 new companies addressing some of healthcare’s most complex challenges, alongside members of the DHNY Hall of Fame, which recognizes organizations whose early and lasting contributions helped build New York’s digital health ecosystem.

“The breadth and depth of companies named to this year’s DH100 reflect a clear market shift from experimentation to execution,” said Bunny Ellerin, co-founder and CEO of DHNY. “These companies are scaling solutions that improve outcomes while building enduring businesses, demonstrating how innovation at the intersection of care delivery, data, and trust is shaping the next generation of healthcare leaders.”

Ascertain's recognition comes on the heels of significant customer traction across oncology and cardiology specialty practices. Ascertain combines embedded AI with human oversight to handle prior authorization workflows end to end. At The Oncology Institute, the model reduced prior authorization work from 350 staff hours a week to under 10, with a first-pass approval rate above 95%. The company scaled its deployment across more than 100 clinics in under eight weeks. At Northwell Health, Ascertain's approach delivered 67% faster submission times and an 80% reduction in clicks per authorization. These results reflect Ascertain's focus on finishing the prior authorization process for both providers and patients, rather than automating a single step and leaving the rest of the burden in place.

To download a copy of the 2026 New York Healthcare Innovation Report, please click here.

About Ascertain

Ascertain is a healthcare technology company using agentic AI to automate complex administrative workflows in healthcare. The company's platform replaces manual tasks, including payer communications, documentation assembly, and eligibility verification, with touchless, intelligent automation. Ascertain was founded in partnership with Northwell Health and Aegis Ventures and is backed by Deerfield Management. For more information, visit www.ascertain.com.

About Digital Health New York (DHNY) 

Digital Health New York (DHNY) is a connected community of digital health leaders who share ideas, spark new directions and create success across the entire ecosystem. As an organization, DHNY seeks to increase the visibility of New York City as a leader in healthcare innovation and showcase the companies and leaders creating the future of healthcare. Its flagship event, DHNY Summit, brings together an elite group of entrepreneurs, investors, payers, providers and executives to cultivate the New York digital health community and drive impactful conversations around the current and future state of digital health. DHNY was founded in 2022 in collaboration with AlleyCorp. For more information or to join DHNY’s mailing list, please visit www.dhny.co.

DH100 Methodology 

To compile the DH100, DHNY invited companies to complete an in-depth application with both quantitative and qualitative measures to get to know the company better. DHNY also used its dynamic database of digital health companies in the region to round out the consideration set. A company qualified for consideration if it maintained headquarters or employed at least 5 people in the New York region. Companies were excluded if: public or non-profit; founded before 2015; on the DH100 five or more years; had an exit. DHNY evaluated companies on a number of factors, including but not limited to: strength of application, leadership, # of employees, funding, revenue, market fit, differentiated  offerings, and community engagement.

‍